Clinical Trial Update: Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A phase 2 study evaluating nivolumab as adjuvant therapy after chemo-radiation in localized muscle-invasive bladder cancer; the trial is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: University of Utah | Conditions: Bladder Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING